CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating Activities:
Net loss	$ 2,738,000	$ 10,779,000
Income from discontinued operations, net of tax	(2,422,000)	(12,392,000)
Gain from sale of discontinued operations, net of tax	(2,970,000)	0
Adjustments to reconcile net loss from continuing operations to net cash provided by (used in) operating activities of continuing operations:
Depreciation and amortization	3,000	0
Stock-based compensation expense	43,000	91,000
Changes in operating assets and liabilities:
Receivable from escrow account	(200,000)	0
Income tax receivable	2,000	4,000
Prepaid expenses and other	(96,000)	64,000
Accounts payable	(41,000)	85,000
Accrued liabilities	630,000	(114,000)
Accrued income taxes	(12,000)	(659,000)
Net cash used in operating activities of continuing operations	(2,325,000)	(2,142,000)
Net cash provided by operating activities of discontinued operations	1,735,000	12,530,000
Net cash (used in) provided by operating activities	(590,000)	10,388,000
Investing Activities:
Proceeds from sale of business	1,581,000	0
Purchases of property and equipment	(24,000)	0
Net cash provided by investing activities of continuing operations	1,557,000	0
Net cash used in investing activities of discontinued operations	(24,000)	(25,000)
Net cash provided by (used in) investing activities	1,533,000	(25,000)
Financing Activities:
Proceeds from issuance of common stock, net	9,000	39,000
Repurchase of common stock, net	(437,000)	0
Net cash (used in) provided by financing activities	(428,000)	39,000
Increase in cash and cash equivalents and restricted cash	515,000	10,402,000
Cash and cash equivalents and restricted cash at beginning of period	14,524,000	3,851,000
Cash and cash equivalents and restricted cash at end of period	15,039,000	14,253,000
Supplemental disclosures for cash flow information:
Cash paid during the period for income taxes	79,000	5,000
Non-cash financing activity:
Purchase of property and equipment included in accounts payable	2,000	0
Common stock issued for accrued liabilities	$ 148,000	$ 0